Marino Stram & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.14M | Sell |
24,413
-553
| -2% | -$64.7K | 0.5% | 33 |
|
|
2026
Q1 | $3M | Buy |
24,966
+255
| +1% | +$29.4K | 0.54% | 32 |
|
|
2025
Q4 | $2.6M | Sell |
24,711
-890
| -3% | -$83.5K | 0.47% | 39 |
|
|
2025
Q3 | $2.15M | Sell |
25,601
-2,018
| -7% | -$166K | 0.39% | 45 |
|
|
2025
Q2 | $2.19M | Sell |
27,619
-4,914
| -15% | -$391K | 0.44% | 38 |
|
|
2025
Q1 | $2.92M | Sell |
32,533
-1,905
| -6% | -$178K | 0.65% | 28 |
|
|
2024
Q4 | $3.43M | Sell |
34,438
-1,012
| -3% | -$104K | 0.76% | 21 |
|
|
2024
Q3 | $4.03M | Buy |
35,450
+232
| +0.7% | +$27.6K | 0.9% | 18 |
|
|
2024
Q2 | $4.36M | Sell |
35,218
-225
| -0.6% | -$29K | 1.07% | 12 |
|
|
2024
Q1 | $4.68M | Sell |
35,443
-80
| -0.2% | -$9.86K | 1.11% | 12 |
|
|
2023
Q4 | $3.87M | Sell |
35,523
-227
| -0.6% | -$23.6K | 1% | 15 |
|
|
2023
Q3 | $3.68M | Sell |
35,750
-488
| -1% | -$52.6K | 1.08% | 13 |
|
|
2023
Q2 | $4.18M | Sell |
36,238
-283
| -0.8% | -$32.1K | 1.18% | 12 |
|
|
2023
Q1 | $3.89M | Buy |
36,521
+204
| +0.6% | +$22K | 1.17% | 12 |
|
|
2022
Q4 | $4.03M | Buy |
36,317
+385
| +1% | +$39.4K | 1.27% | 11 |
|
|
2022
Q3 | $3.09M | Buy |
35,932
+294
| +0.8% | +$26.2K | 1.12% | 12 |
|
|
2022
Q2 | $3.25M | Buy |
35,638
+151
| +0.4% | +$13.4K | 1.13% | 14 |
|
|
2022
Q1 | $2.91M | Sell |
35,487
-1,417
| -4% | -$112K | 0.92% | 18 |
|
|
2021
Q4 | $2.83M | Buy |
36,904
+547
| +2% | +$43.6K | 0.87% | 20 |
|
|
2021
Q3 | $2.73M | Buy |
36,357
+7,864
| +28% | +$598K | 0.94% | 17 |
|
|
2021
Q2 | $2.22M | Sell |
28,493
-7,727
| -21% | -$575K | 0.58% | 49 |
|
|
2021
Q1 | $2.66M | Buy |
36,220
+1,975
| +6% | +$146K | 1.04% | 17 |
|
|
2020
Q4 | $2.67M | Buy |
34,245
+2,036
| +6% | +$156K | 1.19% | 16 |
|
|
2020
Q3 | $2.55M | Buy |
32,209
+1,136
| +4% | +$89K | 1.36% | 14 |
|
|
2020
Q2 | $2.29M | Buy |
31,073
+6,661
| +27% | +$501K | 1.36% | 15 |
|
|
2020
Q1 | $1.79M | Buy |
24,412
+1,877
| +8% | +$148K | 1.38% | 15 |
|
|
2019
Q4 | $1.96M | Buy |
22,535
+221
| +1% | +$18.2K | 1.28% | 16 |
|
|
2019
Q3 | $1.79M | Buy |
22,314
+453
| +2% | +$36.3K | 1.27% | 16 |
|
|
2019
Q2 | $1.75M | Buy |
21,861
+1,070
| +5% | +$81.9K | 1.28% | 16 |
|
|
2019
Q1 | $1.65M | Buy |
20,791
+1,076
| +5% | +$80.5K | 1.19% | 16 |
|
|
2018
Q4 | $1.47M | Sell |
19,715
-50
| -0.3% | -$3.53K | 1.28% | 15 |
|
|
2018
Q3 | $1.34M | Sell |
19,765
-179
| -0.9% | -$11.4K | 1.07% | 18 |
|
|
2018
Q2 | $1.16M | Sell |
19,944
-111
| -0.6% | -$6.26K | 1.03% | 20 |
|
|
2018
Q1 | $1.04M | Sell |
20,055
-58
| -0.3% | -$3.13K | 0.96% | 23 |
|
|
2017
Q4 | $1.08M | Buy |
+20,113
| New | +$1.12M | 1% | 25 |
|
Other funds holding MRK
ECSS
Marino Stram & Associates's MRK Position: Q2 2026 in Review
Marino Stram & Associates reduced its Merck (MRK) stake by 2.2% in Q2 2026, selling an estimated $64.7K and leaving 24,413 shares worth $3.14M. The position accounts for 0.5% of the portfolio, ranked #33.
Marino Stram & Associates first reported a position in MRK in Q4 2017 and has held it in 35 quarters since. The position peaked at $4.68M in Q1 2024. 1,865 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Marino Stram & Associates held 24,413 shares of Merck worth $3.14M as of Q2 2026.
- Marino Stram & Associates sold 553 Merck shares in Q2 2026, an estimated $64.7K.
- Merck made up 0.5% of Marino Stram & Associates's portfolio in Q2 2026, its #33 holding.
- Marino Stram & Associates first reported a position in Merck in Q4 2017 and has held it in 35 quarters since.
- Marino Stram & Associates's Merck position peaked at $4.68M in Q1 2024.
- 1,865 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Marino Stram & Associates's 13F filing for Q2 2026, filed 24 Jul 2026.